Amanote Research

Amanote Research

  • Register
  • Sign In

Peroxisomal Proliferator Activated Receptor-Γ Deficiency in a Canadian Kindred With Familial Partial Lipodystrophy Type 3 (FPLD3)

BMC Medical Genetics- United Kingdom

doi 10.1186/1471-2350-7-3

Full Text

Abstract

Available in

Categories

Genetics

Date

January 14, 2006

Authors

Gordon A FrancisGang LiRobin CaseyJian WangHenian CaoTodd LeffRobert A Hegele

Publisher

Springer Nature


Related search

Familial Partial Lipodystrophy, Köbberling Type

2020Hungarian

Familial Partial Lipodystrophy Type 3: A New Mutation on the PPARG Gene

Hormones
MedicineEndocrinologyMetabolismDiabetes
2015English

Peroxisome Proliferator-Activated Receptor Γ-Mediated Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Peroxisome Proliferator-Activated Receptor-Γ (PPARG; PPARγ)

Science-Business eXchange
2009Latin

Familial Partial Lipodystrophy Type 3 Due to PPARgamma Mutation: Presentation With Diabetes and Severe Hypertriglyceridemia

Endocrine Abstracts
2016English

Nuclear Receptor Coactivator 3 (NCOA3; SRC-3); Peroxisome Proliferator –Activated Receptor-Γ, Coactivator 1α (PGC-1α)

Science-Business eXchange
2008Latin

CIDEC-related Familial Partial Lipodystrophy

2020English

LIPE-related Familial Partial Lipodystrophy

2020English

Effectiveness of Insulin Pump Therapy in a Patient With Familial Partial Lipodystrophy of Dunnigan Type

Journal of Diabetes & Metabolism
2014English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy